| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/28/2005 | US20050089519 Bispecific anti-cd19x anti-cd16 antibodies and uses thereof |
| 04/28/2005 | US20050089518 Prospective identification and characterization of breast cancer stem cells |
| 04/28/2005 | US20050089513 A side population cell separated from human amniotic mesenchymal cell layer, in which expressions of Oct-4 gene, Sox-2 gene and Rex-I gene are observed by RT-PCR, and which is vimentin-positive and CK19-positive in immunocytostaining; useful for therapies of metabolic diseases such as lysosomal disease |
| 04/28/2005 | US20050089511 Methods and compositions comprising DNA damaging agents and p53 |
| 04/28/2005 | US20050089510 Immunization against plaque forming diseases such as cardiovascular disorders with vaccines for disaggregation |
| 04/28/2005 | US20050089501 Composition based on natural substances useful in the maintenance of the correct hydration of the skin |
| 04/28/2005 | US20050089499 Forming a fermentation broth from plants inoculation with microorganisms and fermenttion to produce active component for use on skin and hair |
| 04/28/2005 | CA2551049A1 In vitro method for the diagnosis of cardiovascular functionality of bone marrow precursor cells (bmp) and/or blood-derived circulating precursor cells (bdp) |
| 04/28/2005 | CA2542427A1 Viral fibers |
| 04/28/2005 | CA2542337A1 Cancer gene therapeutic drug |
| 04/28/2005 | CA2542335A1 Cancer gene therapeutic drug |
| 04/28/2005 | CA2542332A1 Immunomodulating compositions and uses therefor |
| 04/28/2005 | CA2542041A1 Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants |
| 04/28/2005 | CA2540657A1 Cell handling device, human tissue regeneration composition, and human tissue regeneration method |
| 04/28/2005 | CA2530412A1 Cartilage and bone repair and regeneration using postpartum-derived cells |
| 04/27/2005 | EP1526185A1 Use of a microorganism or cell to induce autoimmunization of an organism against a tumor |
| 04/27/2005 | EP1526174A2 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/27/2005 | EP1526173A2 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/27/2005 | EP1526171A1 Simultaneous stimulation and concentration of cells |
| 04/27/2005 | EP1526141A2 MHC complexes and uses thereof |
| 04/27/2005 | EP1525308A2 Methods of using jnk or mkk inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 04/27/2005 | EP1253932B1 Botulinum toxin pharmaceutical compositions |
| 04/27/2005 | EP1225814B1 Fibrous-liponutritional complexes and compositions containing them |
| 04/27/2005 | EP1224259A4 Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
| 04/27/2005 | EP1150707B1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 04/27/2005 | EP0850068B1 Lipid extract having anti-inflammatory activity |
| 04/27/2005 | EP0670896B2 Cloning and expression of biologically active alpha-galactosidase a |
| 04/27/2005 | CN1610743A Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/27/2005 | CN1610738A Method of inducing differentiation of mesodermal stem cells, ES cells or immortalized cells into nervous system cells |
| 04/27/2005 | CN1610693A Transdifferentiation of pancreatic acinar cells |
| 04/27/2005 | CN1610502A Surfactant protein for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2005 | CN1608672A Thrombocyte increasing medicine prepn and its prepn process |
| 04/27/2005 | CN1608631A Recipe of medicine for treating piles |
| 04/27/2005 | CN1608513A Health food containing hyaluronic acid and dermatan sulfate |
| 04/27/2005 | CN1198634C Chinese medicine prepn for treating cervical spondylopathy and its prepn process |
| 04/27/2005 | CN1198631C Use of bifidobacteria in preparing medicine for preventing diarrhea |
| 04/27/2005 | CN1198630C Preparation containing dragonfly and male silkworm moth |
| 04/27/2005 | CN1198629C Biology calcium health foods made from sierra fish bone and its preparation method |
| 04/27/2005 | CN1198628C Conditioned cell culture medium compositions and method of use |
| 04/27/2005 | CN1198624C Oligosaccharide mixture |
| 04/27/2005 | CN1198622C Steroidal saponins for treating alzheimer's disease and derivatives thereof |
| 04/26/2005 | US6884785 Compositions and methods for the treatment or prevention of autoimmune diabetes |
| 04/26/2005 | US6884773 Modified hemoglobins, including nitrosylhemoglobins, and uses thereof |
| 04/26/2005 | US6884585 Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor |
| 04/26/2005 | US6884573 Mammalian erythrocytes for use in the storage for allographic and xenographic transfusions |
| 04/26/2005 | US6884456 High-mineral oyster extract and a process for manufacturing the same |
| 04/26/2005 | US6884431 Method for treating proliferative diseases with p27 and fusions thereof |
| 04/26/2005 | US6884415 Antioxidation food product, antioxidation preparation and antioxidation method |
| 04/26/2005 | US6884413 Immunosuppressants for organ transplantions by inducing apoptosis/anergy in T cells; genetic engineering; antigen presenting cells |
| 04/26/2005 | US6884410 Interleukins; for suppressing reactions to alloantigens (graft-versus-host disease/tissue rejection) in organ/bone marrow transplants |
| 04/26/2005 | CA2253871C Ret ligand (retl) for stimulating neural and renal growth |
| 04/26/2005 | CA2152505C Method for preparing a viral aerosol |
| 04/24/2005 | CA2446391A1 Method for inducing t cells regulator with cd47 ligands |
| 04/21/2005 | WO2005035742A2 Methods of preparing and using stem cell compositions and kits comprising the same |
| 04/21/2005 | WO2005035739A1 Regeneration treatment system |
| 04/21/2005 | WO2005035738A1 Cell differentiation of adipose-derived precursor cells |
| 04/21/2005 | WO2005035735A2 Programmable scaffold, and methods for making and using the same |
| 04/21/2005 | WO2005035733A2 Modified whole cell, cell extract and omv-based vaccines |
| 04/21/2005 | WO2005034971A2 Antiviral agent |
| 04/21/2005 | WO2005034970A1 Use of probiotic bacteria in the treatment of infection |
| 04/21/2005 | WO2005034969A1 Medicament on the basis of honey, preparation and use thereof |
| 04/21/2005 | WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | WO2005034843A2 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| 04/21/2005 | WO2005034839A2 Porifera-based therapeutic compositions for treating and preventing skin diseases |
| 04/21/2005 | WO2005017160A3 Mobilization of hematopoietic cells |
| 04/21/2005 | WO2005012509A3 Method for immunotherapy of tumors |
| 04/21/2005 | WO2005006861A3 Double dye method to inactivate blood borne pathogens |
| 04/21/2005 | WO2005001078A3 Regeneration and repair of neural tissue using postpartum-derived cells |
| 04/21/2005 | WO2004100866A3 Alcohol-free transdermal analgesic composition |
| 04/21/2005 | WO2004090112B1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 04/21/2005 | WO2004052273A3 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 04/21/2005 | WO2004045490A3 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
| 04/21/2005 | WO2004041156A3 Method for determining sensitivity to a bacteriophage |
| 04/21/2005 | WO2003093418A3 Keratinocytes expressing exogenous angiogenic growth factors |
| 04/21/2005 | US20050084968 Pluripotent stem cell for use as tool in propagation of cells, tissue and organs to treat disease |
| 04/21/2005 | US20050084967 Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
| 04/21/2005 | US20050084966 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/21/2005 | US20050084964 Progenitor cells which can be differentiated into hepatic, pancreatic and/or salivary gland tissues; tissue engineering and regenerative medicine |
| 04/21/2005 | US20050084963 Purification of lineage-specific cells and uses therefor |
| 04/21/2005 | US20050084960 Propgating human embryonic stem cells in birds and generating specific tissues for use in treatment preferential organ deficiencies; tissue engineering and regenerative medicine |
| 04/21/2005 | US20050084959 Expanding transgenic cord hematopoietic stem cells; tissue engineering and regenerative medicine |
| 04/21/2005 | US20050084542 Osteoinductive bone material |
| 04/21/2005 | US20050084532 Contacting a polymer substrate with a plasticising fluid comprising a liquid or gaseous fluid in its natural or supercritical state to plasticize or swell the polymer to incorporate mammalian, plant and bacterial subcellular, cellular or multicellular matter, liposomes; drug delivery; surgery; grafting |
| 04/21/2005 | US20050084518 For producing beautiful skin and improving constipation, reducing hair loss |
| 04/21/2005 | US20050084512 Non-biodegradable crosslinked polyvinylalcohol derivatized with alkylamino groups which forms a sponge-like scaffold with a plurality of interconnected pores when saturated with aqueous solution; bioartificial organs |
| 04/21/2005 | US20050084499 Comprises polypeptides for use in serodiagnosis and treatment of chlamydial sexually transmitted disease; vaccines |
| 04/21/2005 | US20050084486 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/21/2005 | US20050084484 Administering Lactobacillus plantarum having catalase activity and superoxide dismutase activity as an antiinflammatory agent for rheumatic diseases and psoriasis |
| 04/21/2005 | US20050084482 As an antiinflammatory agent for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 04/21/2005 | US20050084479 Especially lactic acid bacteria as drug delivery devices in combination with edible carriers; tissue targeted therapy |
| 04/21/2005 | CA2542479A1 Sperm protective polypeptides and uses thereof |
| 04/21/2005 | CA2542474A1 Medicament on the basis of honey, preparation and use thereof |
| 04/21/2005 | CA2542120A1 Methods of preparing and using stem cell compositions and kits comprising the same |
| 04/21/2005 | CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | CA2541317A1 Multi-layered polymerizing hydrogels for tissue regeneration |
| 04/21/2005 | CA2540301A1 A dried biotherapeutic composition, uses, and device and methods for administration thereof |
| 04/21/2005 | CA2539346A1 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| 04/21/2005 | CA2538093A1 Porifera-based therapeutic compositions for treating and preventing skin diseases |
| 04/20/2005 | EP1523990A1 Cellular vesicles denoted as 'exosomes', their preparation and use in the stimulation of an immune response |
| 04/20/2005 | EP1523985A1 Strontium agent and method for treating cancer |